Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Since their introduction in clinical practice in the 1950's, Sulfonylureas (SUs) have remained the main-stay of pharmacotherapy in the management of type 2 diabetes. Despite their well-established benefits, their place in therapy is inappropriately being overshadowed by newer therapies. Many of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian J Endocrinol Metab
Autors principals: Kalra, Sanjay, Aamir, A. H., Raza, Abbas, Das, A. K., Azad Khan, A. K., Shrestha, Dina, Qureshi, Md Faisal, Md Fariduddin, Pathan, Md Faruque, Jawad, Fatema, Bhattarai, Jyoti, Tandon, Nikhil, Somasundaram, Noel, Katulanda, Prasad, Sahay, Rakesh, Dhungel, Sanjib, Bajaj, Sarita, Chowdhury, Subhankar, Ghosh, Sujoy, Madhu, S. V., Ahmed, Tofail, Bulughapitiya, Uditha
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2015
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4566336/
https://ncbi.nlm.nih.gov/pubmed/26425465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.163171
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars